Corrigendum: Revisiting the methods for detecting Mycobacterium tuberculosis : what has the new millennium brought thus far?

Autor: Campelo TA; Faculdade de Medicina, Departamento de Patologia e Medicina Legal, Federal University of Ceará, Fortaleza, Brazil., Cardoso de Sousa PR; Faculdade de Medicina, Departamento de Patologia e Medicina Legal, Federal University of Ceará, Fortaleza, Brazil., Nogueira LL; Faculdade de Medicina, Departamento de Patologia e Medicina Legal, Federal University of Ceará, Fortaleza, Brazil., Frota CC; Faculdade de Medicina, Departamento de Patologia e Medicina Legal, Federal University of Ceará, Fortaleza, Brazil., Antas PR; Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

Publikováno v: Access microbiology [Access Microbiol] 2022 Jan 12; Vol. 4 (1), pp. 000294. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2022).

Crucial requirement for standardization during the development of novel recombinant BCG vaccines: Does the corresponding substrain background matter?

Autor: Antas PR; a Laboratório de Imunologia Clínica , Instituto Oswaldo Cruz, Fiocruz , Rio de Janeiro , Brazil.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2016 Dec; Vol. 12 (12), pp. 3099-3102. Date of Electronic Publication: 2016 Jul 25.

Human neonates display altered ex vivo monokine production related to healthy adults.

Autor: Antas PR; Clinical Immunology Laboratory, Oswaldo Cruz Institute-Fiocruz, Rio de Janeiro, Brazil. Electronic address: pzuquim@ioc.fiocruz.br., Pedro TQ; Clinical Immunology Laboratory, Oswaldo Cruz Institute-Fiocruz, Rio de Janeiro, Brazil., Santiago EA; Clinical Immunology Laboratory, Oswaldo Cruz Institute-Fiocruz, Rio de Janeiro, Brazil., Lima JR; Clinical Immunology Laboratory, Oswaldo Cruz Institute-Fiocruz, Rio de Janeiro, Brazil., Silva FC; Gaffree Guinle State University Hospital of Rio de Janeiro, Brazil., Melca LA; Gaffree Guinle State University Hospital of Rio de Janeiro, Brazil., Ponte CG; Clinical Immunology Laboratory, Oswaldo Cruz Institute-Fiocruz, Rio de Janeiro, Brazil.

Publikováno v: Immunology letters [Immunol Lett] 2016 Feb; Vol. 170, pp. 64-7. Date of Electronic Publication: 2015 Dec 11.

A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents.

Autor: Carpenter C; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, 9420 Athena Circle, La Jolla, 92037, USA., Sidney J; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, 9420 Athena Circle, La Jolla, 92037, USA., Kolla R; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, 9420 Athena Circle, La Jolla, 92037, USA., Nayak K; ICGEB-Emory Vaccine Centre, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India., Tomiyama H; Division of Clinical Immunology and Allergy, University of São Paulo Medical School, São Paulo, Brazil., Tomiyama C; Division of Clinical Immunology and Allergy, University of São Paulo Medical School, São Paulo, Brazil., Padilla OA; Division of Clinical Immunology and Allergy, University of São Paulo Medical School, São Paulo, Brazil., Rozot V; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa., Ahamed SF; Division of Infectious Diseases, St. John's Research Institute, St. John's National Academy of Sciences, Sarjapur Road, Koramangala 2 Block, Bangaluru, Karnataka, 560034, India., Ponte C; Clinical Immunology Laboratory, Oswaldo Cruz Institute-Fiocruz, Rio de Janeiro, Brazil., Rolla V; Clinical Immunology Laboratory, Oswaldo Cruz Institute-Fiocruz, Rio de Janeiro, Brazil., Antas PR; Clinical Immunology Laboratory, Oswaldo Cruz Institute-Fiocruz, Rio de Janeiro, Brazil., Chandele A; ICGEB-Emory Vaccine Centre, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India., Kenneth J; Division of Infectious Diseases, St. John's Research Institute, St. John's National Academy of Sciences, Sarjapur Road, Koramangala 2 Block, Bangaluru, Karnataka, 560034, India., Laxmi S; Department of Transfusion Medicine and Immunohematology, St. John's Medical College Hospital, St. John's National Academy of Health Sciences, Bangaluru, 560034, India., Makgotlho E; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa., Vanini V; Translational Research Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases, Rome, Italy., Ippolito G; Translational Research Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases, Rome, Italy., Kazanova AS; Department of Immunology, Federal State Budgetary Scientific Institution 'Central Tuberculosis Research Institute', Moscow, Russia., Panteleev AV; Department of Immunology, Federal State Budgetary Scientific Institution 'Central Tuberculosis Research Institute', Moscow, Russia., Hanekom W; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa., Mayanja-Kizza H; Department of Medicine, College of Health Sciences, Faculty of Medicine, Makerere University, Kampala, Uganda., Lewinsohn D; Oregon Health and Science University, Portland, 97239, USA., Saito M; Johns Hopkins University, Bloomberg School of Public Health, Baltimore, 21205, USA; Universidad Peruana Caytano Hereida, Lima, Peru; Department of Virology, Tohoku University, Sendai, Japan., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, 98109, USA., Boom WH; Tuberculosis Research Unit, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, 44106, USA., Goletti D; Translational Research Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases, Rome, Italy., Gilman R; Johns Hopkins University, Bloomberg School of Public Health, Baltimore, 21205, USA; Universidad Peruana Caytano Hereida, Lima, Peru., Lyadova IV; Department of Immunology, Federal State Budgetary Scientific Institution 'Central Tuberculosis Research Institute', Moscow, Russia., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Department of Pediatrics and Child Health, University of Cape Town, Cape Town, South Africa., Kallas EG; Division of Clinical Immunology and Allergy, University of São Paulo Medical School, São Paulo, Brazil., Murali-Krishna K; ICGEB-Emory Vaccine Centre, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India; Emory Vaccine Center, 1501 Clifton Road, Atlanta, GA, 30329, USA; Department of Pediatrics, Emory University, 1760 Haygood Drive, Atlanta, GA, 30322, USA., Sette A; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, 9420 Athena Circle, La Jolla, 92037, USA., Lindestam Arlehamn CS; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, 9420 Athena Circle, La Jolla, 92037, USA. Electronic address: cecilia@lji.org.

Publikováno v: Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2015 Dec; Vol. 95 (6), pp. 713-721. Date of Electronic Publication: 2015 Aug 01.

In vitro T-cell profile induced by BCG Moreau in healthy Brazilian volunteers.

Autor: Ponte C; a Laboratório de Imunologia Clínica; Instituto Oswaldo Cruz ; Fiocruz , Rio de Janeiro , Brazil., Peres L, Marinho S, Lima J, Siqueira M, Pedro T, De Luca P, Cascabulho C, Castello-Branco LR, Antas PR

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2015; Vol. 11 (2), pp. 450-7.